Fusion Antibodies progresses AI antibody collaboration
21st Aug 2023 13:43
(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies updated the market on its 'AI/ML-Ab', or AIM-Lab, service on Monday.
Read moreContract suspensions see Fusion Antibodies warn on revenue
6th Mar 2023 16:26
(Sharecast News) - Contract research organisation Fusion Antibodies issued a revenue warning on Monday, after a "challenging" first six months of trading as a number of valuable projects were suspended by clients due to delayed investment.
Read moreFusion Antibodies confident after 'challenging' first half
5th Dec 2022 16:28
(Sharecast News) - Contract research organisation Fusion Antibodies reported first-half revenues of £1.9m on Monday, down from £2.4m year-on-year.
Read moreFusion Antibodies reports strong full-year revenue growth
6th May 2022 12:52
(Sharecast News) - Preclinical antibody discovery and supply company Fusion Antibodies reported 14% growth in revenue in a trading update on Friday, to £4.8m.
Read moreFusion Antibodies forms new scientific advisory panel
14th Jan 2022 14:15
(Sharecast News) - Preclinical antibody discovery, engineering and supply company Fusion Antibodies announced the formation of a new scientific advisory panel (SAP) of experts on Friday, to support research and development across its range of antibody services, and to provide advice regarding emerging science and technology issues and trends.
Read moreRevenues rise, losses widen for Fusion Antibodies
6th Dec 2021 11:59
(Sharecast News) - Contract preclinical antibody research provider Fusion Antibodies reported revenues of £2.4m in its first half on Monday, including a one-off milestone of £0.15m, which was up from £1.9m year-on-year.
Read moreFusion Antibodies signs collaborative deal with US biotech firm
7th Oct 2021 11:59
(Sharecast News) - Preclinical antibody discovery and supply company Fusion Antibodies has signed a collaborative research and development agreement with an unnamed US-based biotechnology company which was recently incorporated to focus on a number of innovative early-stage antibody programmes, it announced on Thursday.
Read moreFusion Antibodies performing in line in year-to-date
24th Sep 2021 11:55
(Sharecast News) - Antibody discovery, engineering and supply company Fusion Antibodies said on Friday that revenue growth in the current year had been consistent year-on-year, and in line with its expectations.
Read moreRevenues rise, losses widen for Fusion Antibodies
10th Aug 2021 12:44
(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies reported a 7% improvement in full-year revenues in its final results on Tuesday, to £4.2m.
Read moreFusion Antibodies receives first research milestone payment
23rd Jul 2021 09:32
(Sharecast News) - Preclinical antibody discovery, engineering and supply company Fusion Antibodies has achieved its first research milestone payment as part of its ongoing collaboration with a major client, it announced on Friday.
Read moreFusion Antibodies soars on Covid-19 test progress
18th Sep 2020 09:48
(Sharecast News) - Fusion Antibodies shares soared after the antibody specialist said it had made progress on developing coronavirus antigen tests.
Read moreFusion Antibodies FY revenues continue to grow in 2020
6th Jul 2020 10:41
(Sharecast News) - Pre-clinical antibodies group Fusion Antibodies said on Monday that revenues had continued to grow over the year ending on 31 March.
Read moreFusion Antibodies raises £3m for Covid-19 research
28th Apr 2020 11:19
(Sharecast News) - Fusion Antibodies has raised £3m from investors to extend its research to cover potential treatments for Covid-19.
Read moreFusion Antibodies sees 'favourable trends' continue in H2
29th Jan 2020 09:32
(Sharecast News) - Pre-clinical therapeutic drug and diagnostics firm Fusion Antibodies said on Wednesday that trading in the third quarter of the financial year had continued the "favourable trends" experienced in the first half.
Read moreFusion Antibodies cuts losses after revenue leaps
2nd Dec 2019 11:27
(Sharecast News) - Fusion Antibodies on Monday reported a narrowed loss after revenue more than doubled following the launch of its RAMP service.
Read more